Crossref
CON: Patients With Metastatic/Recurrent Cervical Cancer Should Not be Treated With Cisplatin Plus Paclitaxel
Clinical Ovarian Cancer · 2011
DOI: 10.1016/j.cloc.2012.02.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Ovarian Cancer, 2011. Verfasst von J. Tate Thigpen. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Thigpen, J. T. (2011). CON: Patients With Metastatic/Recurrent Cervical Cancer Should Not be Treated With Cisplatin Plus Paclitaxel. Clinical Ovarian Cancer. https://doi.org/10.1016/j.cloc.2012.02.015
Vancouver
Thigpen JT. CON: Patients With Metastatic/Recurrent Cervical Cancer Should Not be Treated With Cisplatin Plus Paclitaxel. Clinical Ovarian Cancer. 2011. doi:10.1016/j.cloc.2012.02.015
BibTeX
@article{Thigpen2011,
author = {Thigpen, J. Tate},
title = {CON: Patients With Metastatic/Recurrent Cervical Cancer Should Not be Treated With Cisplatin Plus Paclitaxel},
journal = {Clinical Ovarian Cancer},
year = {2011},
doi = {10.1016/j.cloc.2012.02.015}
}
EUVIMED